T-cell immune responses following vaccination with mRNA BNT162b2 against SARS-CoV-2 in patients with chronic lymphocytic leukemia: results from a prospective open-label clinical trial.
Haematologica
; 107(4): 1000-1003, 2022 04 01.
Article
in English
| MEDLINE | ID: covidwho-1630504
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Leukemia, Lymphocytic, Chronic, B-Cell
/
COVID-19
Type of study:
Cohort study
/
Observational study
/
Prognostic study
/
Randomized controlled trials
Topics:
Vaccines
Limits:
Humans
Language:
English
Journal:
Haematologica
Year:
2022
Document Type:
Article
Affiliation country:
Haematol.2021.280300
Similar
MEDLINE
...
LILACS
LIS